Stockreport

Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition." [Yahoo! Finance]

DSS, Inc.  (DSS) 
NASDAQ:AMEX Investor Relations: dsssecure.com
PDF thrilled to announce a milestone in its innovative Laetose™ technology platform. The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent # 11,898,184, entitl [Read more]